Most CRO and clinical vendor contracts say nothing specific about artificial intelligence, even though vendors increasingly use it on sponsor studies. That silence creates risk around data use, accountability and quality. Sponsors should add explicit AI provisions to master services agreements and work orders now, before a problem forces the conversation.
Contract management was a core part of my work across several global CROs. The pattern is consistent: the contract reflects the last generation of risk, not the current one. AI is the current one.
What AI clauses belong in a CRO contract?
Consider these areas for your next MSA or amendment.
Disclosure. Require the vendor to identify which services use AI or machine learning and to notify you of material new uses during the study. You cannot oversee what you do not know about.
Data use and model training. Specify whether your study data, including de-identified data, may be used to train or improve vendor models. Many sponsors assume the answer is no. Many vendor templates assume yes. Settle it in writing.
Validation and documentation. Require that AI tools affecting trial conduct or data be validated for their intended use, with documentation available for sponsor review and regulatory inspection.
Change control. Models get updated. Require notice of material changes to AI tools used on your study, and the right to assess the impact before changes take effect on critical processes.
Human review. For activities affecting participant safety or primary endpoint data, specify that AI outputs are reviewed by qualified personnel before they drive decisions.
Audit and inspection access. Confirm your right to audit AI-assisted processes and that the vendor will support regulatory inspection questions about them.
Liability and remediation. Clarify that use of AI does not reduce the vendor's accountability for performance, and define remediation if an AI-related error affects your data.
Watch for generative AI and confidentiality
A separate but related issue is staff use of general-purpose generative AI tools. If a vendor employee pastes your protocol or safety narratives into a public AI tool, that may breach confidentiality. Ask vendors about their acceptable use policies and require that confidential sponsor information is only processed in approved, secured environments.
Keep it proportionate
Not every vendor needs every clause. A vendor providing translation services needs different terms than one running central monitoring algorithms. Tier your requirements by the risk the vendor's AI use poses to safety, data integrity and confidentiality.
The EU AI Act adds another layer for sponsors operating in Europe, with obligations that depend on how a system is classified. Your legal counsel should assess where that applies. From an operational standpoint, the point is simple: if AI touches your trial, your contract should say how.
ABRA Clinical Consulting advises sponsors on CRO contracting, from proposal review through work order negotiation.
